Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

1.00
Delayed Data
As of 12:07pm ET
 +0.0569 / +6.03%
Today’s Change
0.82
Today|||52-Week Range
4.02
-54.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization520.0K489.0K512.0K613.0K
 
 
 
 
 
 
Operating ExpensesGross Income-520.0K-489.0K-512.0K-613.0K
 
 
 
 
 
General Expenses28.0M40.7M49.8M32.2M
 
 
 
 
 
Research And Development22.0M33.2M41.9M23.5M
 
 
 
 
 
Total Operating Expenses28.5M41.2M50.3M32.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.5M-41.2M-50.3M-32.8M
 
 
 
 
 
Extraordinary Credit25.5M2.3M796.0K128.0K
 
 
 
 
 
Extraordinary Charge-279.0K0.00-500.0K0.00
 
 
 
Interest Expense On Debt309.0K0.000.00--
 
 
Other Expenses24.0K42.0K3.0K7.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.4M-38.8M-50.0M-32.6M
 
 
 
 
 
Net Income-3.4M-38.8M-50.0M-32.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS53.7M62.4M77.6M96.6M
 
 
 
 
 
Shares To Calculate EPS Diluted54.9M62.4M77.6M96.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.62-$0.64-$0.34
 
 
 
 
 
EPS Diluted-$0.53-$0.62-$0.64-$0.34